BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 24332266)

  • 1. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing: ready for the clinics?
    Desai AN; Jere A
    Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
    Friedman K; Resnick MB; Safran H
    R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
    Sabour L; Sabour M; Ghorbian S
    Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing.
    Lopez-Doriga A; Feliubadaló L; Menéndez M; Lopez-Doriga S; Morón-Duran FD; del Valle J; Tornero E; Montes E; Cuesta R; Campos O; Gómez C; Pineda M; González S; Moreno V; Capellá G; Lázaro C
    Hum Mutat; 2014 Mar; 35(3):271-7. PubMed ID: 24227591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent novel approaches for population genomics data analysis.
    Andrews KR; Luikart G
    Mol Ecol; 2014 Apr; 23(7):1661-7. PubMed ID: 24495199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Next Generation Sequencing (NGS) technologies for the genome-wide detection of transposition.
    Elbaidouri M; Chaparro C; Panaud O
    Methods Mol Biol; 2013; 1057():265-74. PubMed ID: 23918435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole cancer genome sequencing by next-generation methods.
    Ross JS; Cronin M
    Am J Clin Pathol; 2011 Oct; 136(4):527-39. PubMed ID: 21917674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Library preparation methods for next-generation sequencing: tone down the bias.
    van Dijk EL; Jaszczyszyn Y; Thermes C
    Exp Cell Res; 2014 Mar; 322(1):12-20. PubMed ID: 24440557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumor sequencing on the use of anticancer drugs.
    Thomas F; Desmedt C; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massively parallel sequencing technology in pathogenic microbes.
    Tripathy S; Jiang RH
    Methods Mol Biol; 2012; 835():271-94. PubMed ID: 22183660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AG-NGS: a powerful and user-friendly computing application for the semi-automated preparation of next-generation sequencing libraries using open liquid handling platforms.
    Callejas S; Álvarez R; Benguria A; Dopazo A
    Biotechniques; 2014 Jan; 56(1):28-35. PubMed ID: 24447136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
    Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
    Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach.
    Hagemann IS; O'Neill PK; Erill I; Pfeifer JD
    Cancer Genet; 2015 Sep; 208(9):441-7. PubMed ID: 26227479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.